Middle East - Israel • Intellectual property
Liad Whatstein & Co. Law Office
Liad Whatstein & Co. Law Office leverages its litigation expertise to assist some of the leading international pharmaceutical companies, as well as clients from the defence and communication technologies sectors, on both complex IP litigation and non-contentious issues. Practice co-head Liad Whatstein is a go-to choice for several pharmaceutical companies in complex litigation cases, and fellow co-head Amira Mangelus is likewise noted for her expertise in patent litigation in the life sciences space. The team also includes patent litigation and technology expert Matti Michel and patent term extension specialist Oren Weiner.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'An incredibly strong and cohesive team. Highly professional and knowledgeable in patent litigation, skilled in strategy development, well aware of international developments and trends.'
- 'Liad Whatstein is a very diligent partner in IP litigation. He is my choice in Israel!'
- 'Liad Whatstein and Amira Mangelus are both passionate, strategic, and very bright.'
'Liad Whatstein is one of the best, if not the best, patent litigation firm in Israel. The team is technically proficient in a wide range of life sciences technologies, inter alia, due to its extensive experience in most major life sciences litigation in Israel and involvement in numerous cross-border proceedings.'
'The team is very diligent and puts forward creative arguments that make it superior to other firms. The firm provides commercially sound advice that enables the client to make pragmatic decisions based on the advice.'
'Liad Whatstein is a technically excellent, diligent and dedicated partner. He is also an excellent cross-examiner and, in general, an excellent lawyer and is the driving force behind the firm.'
'Amira Mangelus has a technical background and extensive experience in complex cross-border litigation. She is one of the founding partners of the firm and provides pragmatic advice.'
Key clients
- Novartis
- Sanofi
- Merck
- Pfizer
- Roche
- Bristol Myers
- Takeda
- Regeneron
- Abbott
- Bayer
- Biogen
- Astellas
- Alkermes
- UCB Pharma
- Alnylam Pharmaceuticals
- H. Lundbeck A/S
- Leo Pharma
- Genzyme
- Novo Nordisk
- L’Oréal
- Unilever
- Amdocs
- The State of Israel
- The Hebrew University
- Sony
- Viacom
- LVMH
- Disney
- Volvo
- Yokogawa Electric Corporation
- Hearst Corporation
- Fruit of the Loom
- Bacardi
- CROCS
- Ralph Lauren
- Kipling
- Tory Burch
- Paramount Pictures Corporation
- The H.D. Lee Company
- Wrangler Apparel Corp.
- The North Face Apparel Corp.
- Jansport Apparel Corp.
- Nautica
- Renault
- VANS
- eBay
- Kanye West
- Brown Forman (Jack Daniel’s)
- Finlandia Vodka
- Grey Goose Vodka
- Spin Master
- Moose Toys
- Elbit Systems
- Finchimica
- InterMune
- ASSA ABLOY
- NBC Universal
- 20th Century Fox
- Marvel
- Dr. Fischer Pharmaceuticals
- Altra
- Triumph Motorcycles
- Harvard University
- Prudential plc
- Fleurop-Interflora
- Homag Group AG
- Immunogen Inc.
- Advanced Accelerator Applications (a Novartis Corporation)
- Eden Gallery
- Fox-Weizel (Israel’s largest chain of apparel outlets)
- HID Corporation (Assa Abloy company)
- Saban Group
- MIT (Massachusetts Institute of Technology)
- University of Georgia Research Foundation, Inc.
- Memo Therapeutics AG
- Axcella Health Inc.
- Innate PharmaS.A.
- Principia Biopharma Inc.
- Translate Bio, Inc
- Ryvu Therapeutics S.A.
- Acceleron Pharma, Inc.
- Arbor Biotechnologies, Inc.
- Kymab Ltd.
- ZURU Toys
- Belvedere Vodka
- Alusense N.V. / Belmoca N.V.
- Hey Dude
- Konti
- Lipton Teas and Infusions
- Tux Creative Co.
- Degussa Bank A.G.
Work highlights
- Represented Sanofi and Regeneron in highly complex proceedings against Amgen’s patent claiming anti-PCSK9 antibodies.
- Represented the State of Israel in litigation against Teva in connection with Teva’s blockbuster drug Copaxone.
- Represented Novartis in litigation against Teva in connection with the manufacture in Israel for export markets of a generic version of the drug fingolimod (Gilenya) which is a blockbuster drug developed by Novartis for the treatment of multiple sclerosis.
Lawyers
Hall of Fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.
Leading individuals
Practice head
The lawyer(s) leading their teams.
Liad Whatstein, Amira Mangelus